Tech Company Financing Transactions
Earlens Funding Round
Aisling Capital, Cochlear and CRG invested in a $118 million venture round for Earlens. The round was announced on 5/26/2017.
Transaction Overview
Company Name
Announced On
5/26/2017
Transaction Type
Debt
Debt
Venture Equity
Venture Equity
Debt
Venture Equity
Venture Equity
Amount
$118,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from those financings will support expanded commercialization of the Earlens Light Driven Hearing Aid, manufacturing scale-up, and next generation R&D pipeline.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4045-A Campbell Ave.
Redwood City, CA 94025
USA
Redwood City, CA 94025
USA
Phone
Website
Email Address
Overview
The Earlens Hearing System is the first hearing aid that uses light to transmit sound, delivering natural sound.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Facteau
Chief Medical Officer
Rodney Perkins
VP - General Counsel
Bernard Shay
VP - Operations
Mark Bishop
VP - R & D
Greg Koskowich
VP - Regulatory Affairs
Judy Brimacombe
VP - Sales
Philip Lyons
Browse more venture capital transactions:
Prev: 5/26/2017: Breast Microseed venture capital transaction
Next: 5/29/2017: Soft Space venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs